Urinary glycan markers for disease

Biochemical Society Transactions

Volumn 39, Issue 1, 2011, Pages 393-398

  Alonzi, Dominic S ^a   Su, Ying Hsiu ^b   Butters, Terry D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Fluorescence; Free oligosaccharide; Glycolipid storage; HPLC

Indexed keywords

BIOLOGICAL MARKER; GLYCAN; GLYCOPROTEIN; GLYCOSPHINGOLIPID; OLIGOSACCHARIDE;

AFFINITY CHROMATOGRAPHY; ANION EXCHANGE CHROMATOGRAPHY; CARBOHYDRATE ANALYSIS; CARCINOGENICITY; CONFERENCE PAPER; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DISEASE MARKER; EARLY DIAGNOSIS; GENETIC DISORDER; GEOGRAPHIC DISTRIBUTION; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; SCREENING TEST; SEX DIFFERENCE; SIALYLATION; SOLID PHASE EXTRACTION; URINALYSIS;

BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE PROGRESSION; GLYCOSYLATION; HUMANS; LIVER NEOPLASMS; POLYSACCHARIDES;

EID: 79551488998     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390393     Document Type: Conference Paper

References (33)

1. Butters, T.D. and Neville, D.C.A. (2008) Glycoprotein Analysis. Molecular Biomethods Handbook (Walker, J.M. and Rapley, R. eds), pp. 495-513, Humana Press, Totowa, NJ
2. Lahiri, S. and Futerman, A.H. (2007) The metabolism and function of sphingolipids and glycosphingolipids. Cell. Mol. Life Sci. 64, 2270-2284
3. Hakomori, S. (1981) Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu. Rev. Biochem. 50, 733-764
4. Reis, C.A., Osorio, H., Silva, L., Gomes, C. and David, L. (2010) Alterations in glycosylation as biomarkers for cancer detection. J. Clin. Pathol. 63, 322-329
5. Hakomori, S. (1996) Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56, 5309-5318
6. Zhao, Y.Y., Takahashi, M., Gu, J.G., Miyoshi, E., Matsumoto, A., Kitazume, S. and Taniguchi, N. (2008) Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci. 99, 1304-1310
7. Abbott, K.L., Aoki, K., Lim, J.M., Porterfield, M., Johnson, R., O'Regan, R.M., Wells, L., Tiemeyer, M. and Pierce, M. (2008) Targeted glycoproteomic identification of biomarkers for human breast carcinoma. J. Proteome Res. 7, 1470-1480
8. Kang, R., Saito, H., Ihara, Y., Miyoshi, E., Koyama, N., Sheng, Y. and Taniguchi, N. (1996) Transcriptional regulation of the N- acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. J. Biol. Chem. 271, 26706-26712
9. Bhaumik, M., Harris, T., Sundaram, S., Johnson, L., Guttenplan, J., Rogler, C. and Stanley, P. (1998) Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression. Cancer Res. 58, 2881-2887
10. Satomaa, T., Heiskanen, A., Leonardsson, I., Angstrom, J., Olonen, A., Blomqvist, M., Salovuori, N., Haglund, C., Teneberg, S., Natunen, J. et al. (2009) Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens. Cancer Res. 69, 5811-5819
11. Hakomori, S. (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. U.S.A. 99, 10231-10233
12. Kannagi, R., Sakuma, K., Miyazaki, K., Lim, K.T., Yusa, A., Yin, J. and Izawa, M. (2010) Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: clues in the ongoing search for new tumor markers. Cancer Sci. 101, 586-593
13. Wang, P.H., Lee, W.L., Juang, C.M., Yang, Y.H., Lo, W.H., Lai, C.R., Hsieh, S.L. and Yuan, C.C. (2005) Altered mRNA expressions of sialyltransferases in ovarian cancers. Gynecol. Oncol. 99, 631-639
14. Imbeaud, S., Ladeiro, Y. and Zucman-Rossi, J. (2010) Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma. Semin. Liver Dis. 30, 75-86
15. Kerr, J.F., Winterford, C.M. and Harmon, B.V. (1994) Apoptosis: its significance in cancer and cancer therapy. Cancer 73, 2013-2026
16. Carmeliet, P. and Jain, R.K. (2000) Angiogenesis in cancer and other diseases. Nature 407, 249-257
17. Renehan, A.G., Zwahlen, M., Minder, C., O'Dwyer, S.T., Shalet, S.M. and Egger, M. (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363, 1346-1353
18. Fuster, M.M. and Esko, J.D. (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer 5, 526-542
19. Abbott, K.L., Nairn, A.V., Hall, E.M., Horton, M.B., McDonald, J.F., Moremen, K.W., Dinulescu, D.M. and Pierce, M. (2008) Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer. Proteomics 8, 3210-3220
20. Alonzi, D.S., Neville, D.C., Lachmann, R.H., Dwek, R.A. and Butters, T.D. (2008) Glucosylated free oligosaccharides are biomarkers of endoplasmic reticulum α-glucosidase inhibition. Biochem. J. 409, 571-580
21. Neville, D.C., Coquard, V., Priestman, D.A., Te Vruchte, D.J., Sillence, D.J., Dwek, R.A., Platt, F.M. and Butters, T.D. (2004) Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling. Anal. Biochem. 331, 275-282
22. Neville, D.C., Dwek, R.A. and Butters, T.D. (2009) Development of a single column method for the separation of lipid- and protein-derived oligosaccharides. J. Proteome Res. 8, 681-687
23. Shibuya, N., Goldstein, I.J., Broekaert, W.F., Nsimba-Lubaki, M., Peeters, B. and Peumans, W.J. (1987) The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J. Biol. Chem. 262, 1596-1601
24. Yamashita, K., Kochibe, N., Ohkura, T., Ueda, I. and Kobata, A. (1985) Fractionation of L-fucose-containing oligosaccharides on immobilized Aleuria aurantia lectin. J. Biol. Chem. 260, 4688-4693
25. Itai, S., Nishikata, J., Yoneda, T., Ohmori, K., Yamabe, H., Arii, S., Tobe, T. and Kannagi, R. (1991) Tissue distribution of 2-3 and 2-6 sialyl Lewis A antigens and significance of the ratio of two antigens for the differential diagnosis of malignant and benign disorders of the digestive tract. Cancer 67, 1576-1587
26. Okada, Y., Jin-no, K., Ikeda, H., Sakai, N., Sotozono, M., Yonei, T., Nakanishi, S., Moriwaki, S. and Tsuji, T. (1994) Changes in the expression of sialyl-Lewisx, a hepatic necroinflammation-associated carbohydrate neoantigen, in human hepatocellular carcinomas. Cancer 73, 1811-1816
27. Auray-Blais, C., Cyr, D., Ntwari, A., West, M.L., Cox-Brinkman, J., Bichet, D.G., Germain, D.P., Laframboise, R., Melancon, S.B., Stockley, T. et al. (2008) Urinary globotriaosylceramide excretion correlates with the genotype in children and adults with Fabry disease. Mol. Genet. Metab. 93, 331-340
28. Barr, C., Clarke, J.T., Ntwari, A., Drouin, R. and Auray-Blais, C. (2009) Fabry disease urinary globotriaosylceramide/creatinine biomarker evaluation by liquid chromatography-tandem mass spectrometry in healthy infants from birth to 6 months. Mol. Genet. Metab. 97, 278-283
29. Bodennec, J., Koul, O., Aguado, I., Brichon, G., Zwingelstein, G. and Portoukalian, J. (2000) A procedure for fractionation of sphingolipid classes by solid-phase extraction on aminopropyl cartridges. J. Lipid Res. 41, 1524-1531
30. An, Y., Young, S.P., Hillman, S.L., Van Hove, J.L., Chen, Y.T. and Millington, D.S. (2000) Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease. Anal. Biochem. 287, 136-143
31. Durand, G. and Seta, N. (2000) Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. Clin. Chem. 46, 795-805
32. Fuller, M., Rozaklis, T., Ramsay, S.L., Hopwood, J.J. and Meikle, P.J. (2004) Disease-specific markers for the mucopolysaccharidoses. Pediatr. Res. 56, 733-738
33. Yin, J., Miyazaki, K., Shaner, R.L., Merrill, A.H., Jr. and Kannagi, R. (2010) Altered sphingolipid metabolism induced by tumor hypoxia: new vistas in glycolipid tumor markers. FEBS Lett. 584, 1872-1878